Viewing
|Articles|March 1, 2010

Patient-centred research provides a better understanding of the impact of bottle modifications on glaucoma patients

Sponsored Feature. Xalatan® is to become available across Europe in a newly designed bottle. So what does that mean and what lies behind that decision?

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe

Latest CME